journal article·2025-05-01Open access

Plant Iridoids Affect Intraocular Pressure and Vascular Flow in the Rabbit Eye

Dorota Szumny, Tomasz Sozański, Adam Szeląg, Antoni Szumny

Applied Sciences· Volume 15· Issue 9

Abstract

For plant-derived raw materials, there are very few studies regarding the effect of intraocular administration on intraocular pressure (IOP) and associated blood flow. Traditional folk medicine uses many natural resources for eye disorders. However, in the main, these exhibit an anti-inflammatory and moisturizing effect. The intraocular pressure reduction and neuroprotective effects are known, but only for orally administered products. In the work presented here, the effect of eight natural iridoids in concentrations of 0.1 and 0.5% in saline on IOP and blood flow in iris vessels was studied in white New Zealand rabbits. No ocular adverse effects were observed during the whole experiment. We demonstrated, for the first time, significant reductions in IOP for five of the eight iridoids tested at a concentration of 0.5%. These were verbenalin, aucubin, oleuropein, gentiopicroside, and secologanin. The highest effect of IOP lowering, a nearly 1.5 mmHg difference from baseline, was observed for verbenalin 2 h after administration. An increase in vascular inflow was observed only with the administration of aucubin, catalpol, and gentiopicroside at 2 and 3 h after administration of the 0.5% solution. This effect was contrary to the result for the reference—timolol—which significantly reduced flow by more than 100 flux during the first hours of the experiment. In summary, selected iridoids could be considered, after further investigation, as natural components for ophthalmic formulation in the prevention of eye diseases.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Phytochemistry and Biological Activities · Flavonoids in Medical Research · Saffron Plant Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmacology, Wroclaw Medical University, Mikulicza-Radeckiego 2, 50-345 Wroclaw, Poland

Ophthalmology Clinic, Uniwersytecki Szpital Kliniczny, Borowska 213, 50-556 Wrocław, Poland

Department of Preclinical Sciences, Pharmacology and Medical Diagnostics, Faculty of Medicine, Wroclaw University of Science and Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland

Department of Food Chemistry and Biocatalysis, Wrocław University of Environmental and Life Sciences, Norwida 25, 50-375 Wrocław, Poland

Funding

Wroclaw Medical University

References (58)

Show source-provided references
1. Iridoids and active ones in patrinia: A review10.1016/j.heliyon.2023.e16518 ↗
2. Recent advances in Iridoid chemistry: Biosynthesis and chemical synthesis10.1002/asia.202001034 ↗
3. Bioactive Herbal Medicine Use for Eye Sight: A Meta Analysis10.55544/jrasb.1.3.6 ↗
4. Assessment of eyebright (Euphrasia officinalis L.) extract activity in relation to human corneal cells using in vitro tests10.5152/balkanmedj.2014.8377 ↗
5. A review of plant species used to treat conjunctivitis10.1002/ptr.1076 ↗
6. Review of complementary and alternative medicine in treatment of ocular allergies10.1097/00130832-200310000-00013 ↗
7. Kang, W.S., Jung, E., and Kim, J. (2018). Aucuba japonica Extract and Aucubin Prevent Desiccating Stress-Induced Corneal Epithelial Cell Injury and Improve Tear Secretion in a Mouse Model of Dry Eye Disease. Molecules, 23.10.3390/molecules23102599 ↗
8. The Pathophysiology and Treatment of Glaucoma10.1001/jama.2014.3192 ↗
9. The number of people with glaucoma worldwide in 2010 and 202010.1136/bjo.2005.081224 ↗
10. Targets of Neuroprotection in Glaucoma10.1089/jop.2017.0041 ↗
11. Characteristics and Outcomes of Retinal Artery Occlusion: Nationally Representative Data10.1161/STROKEAHA.119.027034 ↗
12. Current treatment of central retinal artery occlusion: A national survey10.1007/s00415-017-8702-x ↗
13. Global epidemiology of retinal vein occlusion: A systematic review and meta-analysis of prevalence, incidence, and risk factors10.7189/jogh.09.010427 ↗
14. Efficacy and safety of 1% forskolin eye drops in open angle glaucoma–An open label study10.1016/j.sjopt.2015.02.003 ↗
15. Application of cornelian cherry iridoid-polyphenolic fraction and Loganic acid to reduce intraocular pressure
16. Forskolin and derivatives as tools for studying the role of cAMP
17. Forskolin: Upcoming antiglaucoma molecule10.4103/0022-3859.101396 ↗
18. Senapati, S., Youssef, A.A.A., Sweeney, C., Cai, C., Dudhipala, N., and Majumdar, S. (2022). Cannabidiol loaded topical ophthalmic nanoemulsion lowers intraocular pressure in normotensive Dutch-belted rabbits. Pharmaceutics, 14.10.3390/pharmaceutics14122585 ↗
19. Cannabinoid applications in glaucoma10.1016/j.oftal.2010.11.015 ↗
20. Multiple-drop study of topically applied 1% delta 9-tetrahydrocannabinol in human eyes10.1001/archopht.1983.01040010591012 ↗
21. Intraocular pressure following systemic administration of cannabinoids10.3109/02713688209011626 ↗
22. Δ9-Tetrahydrocannabinol and cannabidiol differentially regulate intraocular pressure10.1167/iovs.18-24838 ↗
23. Development of a Δ9-tetrahydrocannabinol amino acid-dicarboxylate prodrug with improved ocular bioavailability10.1167/iovs.16-20757 ↗
24. Topical trans-resveratrol ameliorates steroid-induced anterior and posterior segment changes in rats10.1016/j.exer.2015.09.014 ↗
25. Davis, B.M., Pahlitzsch, M., Guo, L., Balendra, S., Shah, P., Ravindran, N., Malaguarnera, G., Sisa, C., Shamsher, E., and Hamze, H. (2018). Topical curcumin nanocarriers are neuroprotective in eye disease. Sci. Rep., 8.10.1038/s41598-018-29393-8 ↗
26. The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma10.1076/ceyr.28.3.153.26246 ↗
27. Visual improvement in a patient taking ginkgo biloba extract: A case study10.1016/j.explore.2007.04.011 ↗
28. Effect of Ginkgo biloba on visual field and contrast sensitivity in Chinese patients with normal tension glaucoma: A randomized, crossover clinical trial10.1167/iovs.13-13168 ↗
29. Lee, L.-Y., Hsu, J.-H., Fu, H.-I., Chen, C.-C., and Tung, K.-C. (2022). Lowering the intraocular pressure in rats and rabbits by cordyceps cicadae extract and its active compounds. Molecules, 27.10.3390/molecules27030707 ↗
30. Effects of French maritime pine bark/bilberry fruit extracts on intraocular pressure for primary open-angle glaucoma10.3164/jcbn.20-50 ↗
31. Catalpol ameliorates diabetic atherosclerosis in diabetic rabbits
32. Catalpol restores LPS-elicited rat microcirculation disorder by regulation of a network of signaling involving inhibition of TLR-4 and SRC10.1152/ajpgi.00159.2016 ↗
33. Lyophilized Powder of Catalpol and Puerarin Protected Cerebral Vessels from Ischemia by Its Anti-apoptosis on Endothelial Cells10.7150/ijbs.17751 ↗
34. Catalpol stimulates VEGF production via the JAK2/STAT3 pathway to improve angiogenesis in rats’ stroke model10.1016/j.jep.2016.06.030 ↗
35. Sun, Y., Ji, J., Zha, Z., Zhao, H., Xue, B., Jin, L., and Wang, L. (2021). Effect and Mechanism of Catalpol on Remyelination via Regulation of the NOTCH1 Signaling Pathway. Front. Pharmacol., 12.10.3389/fphar.2021.628209 ↗
36. Therapeutic potential of catalpol and geniposide in Alzheimer’s and Parkinson’s diseases: A snapshot of their underlying mechanisms10.1016/j.brainresbull.2021.06.020 ↗
37. Protective effects of catalpol on mitochondria of hepatocytes in cholestatic liver injury10.3892/mmr.2020.11337 ↗
38. The effect of oleuropein on unilateral ureteral obstruction induced-kidney injury in rats: The role of oxidative stress, inflammation and apoptosis10.1007/s11033-019-05237-0 ↗
39. Effect of Morinda citrifolia fruit extract and its iridoid glycosides on blood fluidity10.1007/s11418-014-0826-z ↗
40. Aucubin promotes angiogenesis via estrogen receptor beta in a mouse model of hindlimb ischemia10.1016/j.jsbmb.2017.07.007 ↗
41. Aucubin protects against retinal ganglion cell injury in diabetic rats via inhibition of the p38MAPK pathway
42. Park, S.-B., Jung, W.K., Yu, H.-Y., Kim, Y.H., and Kim, J. (2022). Effect of Aucubin-Containing Eye Drops on Tear Hyposecretion and Lacrimal Gland Damage Induced by Urban Particulate Matter in Rats. Molecules, 27.10.3390/molecules27092926 ↗
43. Zhai, L., Liu, M., Wang, T., Zhang, H., Li, S., and Guo, Y. (2017). Picroside II protects the blood-brain barrier by inhibiting the oxidative signaling pathway in cerebral ischemia-reperfusion injury. PLoS ONE, 12.10.1371/journal.pone.0174414 ↗
44. Wang, T., Zhao, L., Guo, Y., Zhang, M., and Pei, H. (2015). Picroside II Inhibits Neuronal Apoptosis and Improves the Morphology and Structure of Brain Tissue following Cerebral Ischemic Injury in Rats. PLoS ONE, 10.10.1371/journal.pone.0124099 ↗
45. Gelatin microspheres encapsulated with a nonpeptide angiogenic agent, ginsenoside Rg1, for intramyocardial injection in a rat model with infarcted myocardium10.1016/j.jconrel.2007.04.005 ↗
46. Li, S., Wu, C., Chen, J., Lu, P., Chen, C., Fu, M., Fang, J., Gao, J., Zhu, L., and Liang, R. (2013). An effective solution to discover synergistic drugs for anti-cerebral ischemia from traditional Chinese medicinal formulae. PLoS ONE, 8.10.1371/journal.pone.0078902 ↗
47. Effects of oleuropein and pinoresinol on microvascular damage induced by hypoperfusion and reperfusion in rat pial circulation10.1111/micc.12175 ↗
48. Gentiopicroside Ameliorates Diabetic Peripheral Neuropathy by Modulating PPAR-Γ/AMPK/ACC Signaling Pathway10.1159/000494174 ↗
49. The neuroprotective role of morroniside against spinal cord injury in female rats10.1016/j.neuint.2021.105105 ↗
50. Loganin and catalpol exert cooperative ameliorating effects on podocyte apoptosis upon diabetic nephropathy by targeting AGEs-RAGE signaling10.1016/j.lfs.2020.117653 ↗
51. Loganin enhances long-term potentiation and recovers scopolamine-induced learning and memory impairments10.1016/j.physbeh.2016.12.043 ↗
52. Fan, N., Wang, P., Tang, L., and Liu, X. (2015). Ocular Blood Flow and Normal Tension Glaucoma. BioMed Res. Int., 2015.10.1155/2015/308505 ↗
53. Ocular blood flow in glaucoma—The Leuven Eye Study10.1111/j.1755-3768.2016.0135 ↗
54. Neuroprotection: A versatile approach to combat glaucoma10.1016/j.ejphar.2020.173208 ↗
55. The molecular basis of retinal ganglion cell death in glaucoma10.1016/j.preteyeres.2011.11.002 ↗
56. Neuroprotection for treatment of glaucoma in adults
57. Injectable and 3D Extrusion Printable Hydrophilic Silicone-Based Hydrogels for Controlled Ocular Delivery of Ophthalmic Drugs10.1021/acsabm.4c00901 ↗
58. Research progress review of preparation and applications of fluorescent hydrogels10.1155/2020/8246429 ↗